MedTrace Logo

Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction

NCT01595360 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2013-09-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety, tolerability and efficacy of TT-173 in healthy volunteers after tooth extraction.

Conditions

  • Tooth Extraction

Interventions

DRUG

Placebo

It is applied directly to the bleeding site after tooth extraction

DRUG

TT-173

It is applied directly to the bleeding site after tooth extraction

Sponsors & Collaborators

  • Thrombotargets Europe S.L

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01595360 on ClinicalTrials.gov